Amman: Jordan’s therapeutic industries and medical supplies sector has reached an impressive annual production capacity of JD1.6 billion. This sector, which includes a wide range of products such as human, therapeutic, and veterinary medicines, as well as medical devices and nutritional supplements, is a significant contributor to the Kingdom’s industrial output.
According to Jordan News Agency, Dr. Fadi Atrash, the sector’s representative at the Jordan Chamber of Industry (JCI), emphasized the strategic importance of the therapeutic industries and medical supplies sector to the national economy. He highlighted the sector’s integration with other healthcare-related industries and its reliance on specialized scientific workers, including chemists and biologists.
Dr. Atrash noted that the sector comprises 151 operating establishments and contributes approximately 3% to Jordan’s GDP, with a value-added rate of 51% of total production. The sector also plays a crucial role in employment, providing jobs for about
10,000 workers, 95% of whom are local, with women making up 35% of the workforce.
Exports from the sector are a significant economic driver, reaching JD612 million last year and covering 80 international markets. Key export destinations include Saudi Arabia, Iraq, Algeria, the UAE, and the United States. The sector’s inclusion in the Economic Modernization Vision aims to transform it into a regional hub for pharmaceutical products over the next decade, with targets to boost exports to over JD2.1 billion and increase employment to 16,000 workers.
Dr. Atrash also acknowledged the critical role of the Jordan Food and Drug Administration in supporting the sector’s growth through modern legislation and continuous industry oversight.